Jefferies analyst David Hayes has maintained their bullish stance on 0KFX stock, giving a Buy rating on February 13.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
David Hayes has given his Buy rating due to a combination of factors related to Danone’s exposure to the Chinese infant milk formula market. He interprets A2 Milk’s upgraded guidance and confirmation of strong category trends, including Aptamil’s share gains, as evidence that Danone is benefitting from a healthier competitive and demand backdrop in China IMF.
He also notes that while a sharp drop in 2025 newborns will pressure demand later on, this headwind should be partially offset by resilient Stage‑3 consumption from Dragon‑year babies and structurally lower breastfeeding rates. Looking ahead, the expected recovery in births from 2026, supported by higher marriage registrations and policy support, underpins a more favorable medium‑term volume outlook, reinforcing the case for a Buy rating on Danone.
In another report released on February 13, Barclays also maintained a Buy rating on the stock with a €83.00 price target.